Form 4 for LLY Lilly (Eli)
Accepted 2025-10-09 00:00:00 ET · period of report 2025-10-08 · accession 0000316011-25-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-10-09 | 2025-10-08 | LLY | LILLY ENDOWMENT INC | 10% | S - Sale | $850.28 | -101.4K | 94.55M | -0.1% | -$86.23M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-08 | S | D | 946 | $854.64 | 94,547,780 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $854.42 to $855.25, inclusive. |
| 2 | Common | Common Stock | 2025-10-08 | S | D | 3,881 | $853.85 | 94,548,726 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $853.25 to $854.21, inclusive. |
| 3 | Common | Common Stock | 2025-10-08 | S | D | 3,227 | $852.36 | 94,552,607 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $852.05 to $853.01, inclusive. |
| 4 | Common | Common Stock | 2025-10-08 | S | D | 13,624 | $851.40 | 94,555,834 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $851.00 to $851.98, inclusive. |
| 5 | Common | Common Stock | 2025-10-08 | S | D | 36,114 | $850.52 | 94,569,458 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $850.00 to $850.99, inclusive. |
| 6 | Common | Common Stock | 2025-10-08 | S | D | 25,296 | $849.60 | 94,605,572 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $849.00 to $849.99, inclusive. |
| 7 | Common | Common Stock | 2025-10-08 | S | D | 18,132 | $848.46 | 94,630,868 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $848.00 to $848.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), and (7) to this Form 4. |
| 8 | Common | Common Stock | 2025-10-08 | S | D | 200 | $856.00 | 94,547,580 | D | — | — |